Cargando…

Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats

Childhood absence epilepsy (CAE) is characterized by absence seizures, which are episodes of lack of consciousness accompanied by electrographic spike-wave discharges. About 60% of children and adolescents with absence seizures are affected by major neuropsychological comorbidities, including anxiet...

Descripción completa

Detalles Bibliográficos
Autores principales: De Deurwaerdère, Philippe, Casarrubea, Maurizio, Cassar, Daniel, Radic, Manuela, Puginier, Emilie, Chagraoui, Abdeslam, Crescimanno, Giuseppe, Crunelli, Vincenzo, Di Giovanni, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169225/
https://www.ncbi.nlm.nih.gov/pubmed/35677756
http://dx.doi.org/10.3389/fncel.2022.886033
_version_ 1784721163361976320
author De Deurwaerdère, Philippe
Casarrubea, Maurizio
Cassar, Daniel
Radic, Manuela
Puginier, Emilie
Chagraoui, Abdeslam
Crescimanno, Giuseppe
Crunelli, Vincenzo
Di Giovanni, Giuseppe
author_facet De Deurwaerdère, Philippe
Casarrubea, Maurizio
Cassar, Daniel
Radic, Manuela
Puginier, Emilie
Chagraoui, Abdeslam
Crescimanno, Giuseppe
Crunelli, Vincenzo
Di Giovanni, Giuseppe
author_sort De Deurwaerdère, Philippe
collection PubMed
description Childhood absence epilepsy (CAE) is characterized by absence seizures, which are episodes of lack of consciousness accompanied by electrographic spike-wave discharges. About 60% of children and adolescents with absence seizures are affected by major neuropsychological comorbidities, including anxiety. Endocannabinoids and monoamines are likely involved in the pathophysiology of these CAE psychiatric comorbidities. Here, we show that the synthetic cannabinoid receptor type 1/2 (CB1/2R) agonist WIN 55,212-2 (2 mg/kg) has a strain-dependent effect on anxiety-like and motor behavior when assess in the hole board test and cerebral monoaminergic levels in Genetic Absence Epilepsy Rats from Strasbourg (GAERS) and their non-epileptic control (NEC) rat strain. Using quantitative and Temporal pattern (T-pattern) analyses, we found that WIN 55,212-2 did not affect the emotional status of GAERS, but it was anxiolytic in NEC. Conversely, WIN 55,212-2 had a sedative effect in GAERS but was ineffective in NEC. Moreover, vehicle-treated GAERS more motivated to explore by implementing more complex and articulated strategies. These behavioral changes correlate with the reduction of 5-HT in the hippocampus and substantia nigra (SN) and noradrenaline (NA) in the entopeduncular nucleus (EPN) in vehicle-treated GAERS compared to NEC rats, which could contribute to their low anxiety status and hypermotility, respectively. On the other hand, the increased level of NA in the EPN and 5-HT in the SN is consistent with an activation of the basal ganglia output-mediated motor suppression observed in WIN 55,212-2-treated GAERS rats. These data support the view of a strain-dependent alteration of the endocannabinoid system in absence epilepsy by adding evidence of a lower emotional responsiveness and a basal ganglia hypersensitivity to cannabinoids in GAERS compared to NEC rats.
format Online
Article
Text
id pubmed-9169225
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91692252022-06-07 Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats De Deurwaerdère, Philippe Casarrubea, Maurizio Cassar, Daniel Radic, Manuela Puginier, Emilie Chagraoui, Abdeslam Crescimanno, Giuseppe Crunelli, Vincenzo Di Giovanni, Giuseppe Front Cell Neurosci Neuroscience Childhood absence epilepsy (CAE) is characterized by absence seizures, which are episodes of lack of consciousness accompanied by electrographic spike-wave discharges. About 60% of children and adolescents with absence seizures are affected by major neuropsychological comorbidities, including anxiety. Endocannabinoids and monoamines are likely involved in the pathophysiology of these CAE psychiatric comorbidities. Here, we show that the synthetic cannabinoid receptor type 1/2 (CB1/2R) agonist WIN 55,212-2 (2 mg/kg) has a strain-dependent effect on anxiety-like and motor behavior when assess in the hole board test and cerebral monoaminergic levels in Genetic Absence Epilepsy Rats from Strasbourg (GAERS) and their non-epileptic control (NEC) rat strain. Using quantitative and Temporal pattern (T-pattern) analyses, we found that WIN 55,212-2 did not affect the emotional status of GAERS, but it was anxiolytic in NEC. Conversely, WIN 55,212-2 had a sedative effect in GAERS but was ineffective in NEC. Moreover, vehicle-treated GAERS more motivated to explore by implementing more complex and articulated strategies. These behavioral changes correlate with the reduction of 5-HT in the hippocampus and substantia nigra (SN) and noradrenaline (NA) in the entopeduncular nucleus (EPN) in vehicle-treated GAERS compared to NEC rats, which could contribute to their low anxiety status and hypermotility, respectively. On the other hand, the increased level of NA in the EPN and 5-HT in the SN is consistent with an activation of the basal ganglia output-mediated motor suppression observed in WIN 55,212-2-treated GAERS rats. These data support the view of a strain-dependent alteration of the endocannabinoid system in absence epilepsy by adding evidence of a lower emotional responsiveness and a basal ganglia hypersensitivity to cannabinoids in GAERS compared to NEC rats. Frontiers Media S.A. 2022-05-23 /pmc/articles/PMC9169225/ /pubmed/35677756 http://dx.doi.org/10.3389/fncel.2022.886033 Text en Copyright © 2022 De Deurwaerdère, Casarrubea, Cassar, Radic, Puginier, Chagraoui, Crescimanno, Crunelli and Di Giovanni. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
De Deurwaerdère, Philippe
Casarrubea, Maurizio
Cassar, Daniel
Radic, Manuela
Puginier, Emilie
Chagraoui, Abdeslam
Crescimanno, Giuseppe
Crunelli, Vincenzo
Di Giovanni, Giuseppe
Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
title Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
title_full Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
title_fullStr Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
title_full_unstemmed Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
title_short Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
title_sort cannabinoid 1/2 receptor activation induces strain-dependent behavioral and neurochemical changes in genetic absence epilepsy rats from strasbourg and non-epileptic control rats
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169225/
https://www.ncbi.nlm.nih.gov/pubmed/35677756
http://dx.doi.org/10.3389/fncel.2022.886033
work_keys_str_mv AT dedeurwaerderephilippe cannabinoid12receptoractivationinducesstraindependentbehavioralandneurochemicalchangesingeneticabsenceepilepsyratsfromstrasbourgandnonepilepticcontrolrats
AT casarrubeamaurizio cannabinoid12receptoractivationinducesstraindependentbehavioralandneurochemicalchangesingeneticabsenceepilepsyratsfromstrasbourgandnonepilepticcontrolrats
AT cassardaniel cannabinoid12receptoractivationinducesstraindependentbehavioralandneurochemicalchangesingeneticabsenceepilepsyratsfromstrasbourgandnonepilepticcontrolrats
AT radicmanuela cannabinoid12receptoractivationinducesstraindependentbehavioralandneurochemicalchangesingeneticabsenceepilepsyratsfromstrasbourgandnonepilepticcontrolrats
AT puginieremilie cannabinoid12receptoractivationinducesstraindependentbehavioralandneurochemicalchangesingeneticabsenceepilepsyratsfromstrasbourgandnonepilepticcontrolrats
AT chagraouiabdeslam cannabinoid12receptoractivationinducesstraindependentbehavioralandneurochemicalchangesingeneticabsenceepilepsyratsfromstrasbourgandnonepilepticcontrolrats
AT crescimannogiuseppe cannabinoid12receptoractivationinducesstraindependentbehavioralandneurochemicalchangesingeneticabsenceepilepsyratsfromstrasbourgandnonepilepticcontrolrats
AT crunellivincenzo cannabinoid12receptoractivationinducesstraindependentbehavioralandneurochemicalchangesingeneticabsenceepilepsyratsfromstrasbourgandnonepilepticcontrolrats
AT digiovannigiuseppe cannabinoid12receptoractivationinducesstraindependentbehavioralandneurochemicalchangesingeneticabsenceepilepsyratsfromstrasbourgandnonepilepticcontrolrats